Ephesoft Receives 2014 Best of Irvine Award LAGUNA HILLS,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ephesoft Receives 2014 Best of Irvine Award

LAGUNA HILLS, Calif., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Ephesoft, Inc., creator of the industry-leading Smart Capture™ advanced document capture platform, has been selected for the 2014 Best of Irvine Award in the Software Company category.

Each year, the Irvine Award Program identifies area companies that achieve notable marketing success in the local community and in their business category. Recognition is given to organizations that demonstrate the ability to use their best practices and programs to generate long-term value for clients, and ultimately generate a strong competitive advantage.

"It's a real pleasure to be recognized for our efforts," offered Don Field, CEO of Ephesoft. "Our dedicated team of professionals strives every day to serve our customers well, and they truly earned this award. When you place the customer first, your business succeeds, and our tremendous growth especially this year proves that. We are humbled by this recognition and will continue to work closely with our partners and customers to provide real value to their operations."

Various sources of information were gathered and analyzed to choose the winners in each category. The Irvine Award Program focuses on quality, not quantity. Winners are determined based on information gathered both internally by the Irvine Award Program and data provided by third parties.

The Irvine Award Program was established to recognize the best of local businesses in Irvine and surrounding communities. The organization works extensively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Their mission is to recognize the small business community's contributions to the U.S. economy.

About Ephesoft:

Ephesoft, Inc. delivers our exclusive Smart Capture™ intelligent capture technology on-premise or in a SaaS model. With a focus on efficiency and reliability, Ephesoft has crafted the next generation of intelligent document capture in a simple and cost-effective application. Ephesoft's use of open standards and web-based software offers extreme flexibility and accessibility for a wide range of customers. Our superior classification technology allows organizations to automate and streamline mailroom processing and other document-based business processes. Ephesoft software captures and extracts data from unstructured documents with ease, adding another layer of efficiency and cost-savings to your operation.

Ephesoft is headquartered in Laguna Hills, California, with additional offices in Dallas, Tampa, and St. Louis and EMEA operations in Reading, England. The company is undergoing rapid growth and has customers in over 25 countries. To learn more, please visit www.ephesoft.com or call 949-335-5335.

© 2014 Ephesoft. Smart Capture™ is a registered trademark

Media Contact(s) Ephesoft: Cristina Rivera +1 949 335 5335 ext.521 Irvine Award Program Email: URL: http://www.awardclaim.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles